The correlation between lipoprotein associated phospholipase A(2) and central overweight status

Objective: Being overweight is associated with an increased risk of diabetes mellitus, hypertension, and cardiovascular disease. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) can independently predict the risk of cardiovascular disease. This study is aimed to investigate whether Lp-PLA(2) was associated with an overweight status. Methods: This was a cross-sectional study that enrolled 3760 Chinese adults (age, 18–50 years) who underwent medical examination department of Xiamen Chang-Gung Hospital (XCGH) from 2018 to 2020. To explore the distribution of overweight classifications in the Chinese population, we evaluated the correlation of the overweight status with Lp-PLA(2), after correcting for possible influencing factors. Results: The Lp-PLA(2) level was greater in male than in female subjects (p < 0.001). Subjects with a central overweight status had a greater Lp-PLA(2) level than those with normal weight and a peripheral overweight status, in both male and female cohorts. The Lp-PLA(2) level was significantly greater in those with additional comorbidities (namely diabetes mellitus (DM), hypertension (HTN), overweight, and metabolic syndrome (MetS)). The age-adjusted and LDL-adjusted Lp-PLA(2) level also was significantly higher in the DM (+) and HTN (−) subgroups than in the DM (−), HTN (−), DM (−), and HTN (+) subgroups. Conclusion: Lp-PLA(2) is associated with sex, central overweight status, diabetes, hypertension, and MetS in adults aged < 50 years and the age-adjusted and LDL-adjusted Lp-PLA(2) was significantly higher in the DM (+) and HTN (−) subgroups than in the DM (−) and HTN (−) and DM (−) and HTN (+) subgroups.